From digital ambition to accountable value
Why Ola Kotun's 2024 Munich summit appearance put practical value, accountability and context around digital health investment.
In November 2024, a question at the heart of health technology gathered a room in Munich: how should organisations know whether digital investment is producing value? The Digital Health Summit, known as dhs2024, placed that question within a setting designed for serious exchange, rather than presenting technology as an end in itself. Hosted from 6 to 8 November at TranslaTUM, Klinikum rechts der Isar, Technical University of Munich, the event brought together perspectives from hospitals, academic centres of excellence and industry.
That context explains the significance of Ola Kotun’s documented appearance. The summit invited her as a panel and keynote speaker for “Digital Transformation in Health Care: How to get the value out of your digital health investments.” The wording is deliberately practical. It points towards the difficult work that follows a purchase or pilot: deciding what value means, identifying the conditions for it, and asking whether a proposed change can make a meaningful difference for patients and the organisations serving them.
A mention on the summit record therefore says more than that a speaker occupied a programme slot. It places Kotun in a conversation about translation: moving from digital ambition to measurable patient benefit, while accounting for the clinical and operating-model conditions that shape whether an initiative works in practice. That is a useful editorial distinction in a field often crowded with broad promises. The record documents a subject and a role, not a guaranteed result.
The venue adds another layer. TranslaTUM sits within Klinikum rechts der Isar and the Technical University of Munich, making the location a natural backdrop for discussion across healthcare delivery, research and technology. The summit’s stated mix of hospital leaders, academic centres of excellence and industry creates a frame for examining digital health investments from more than one institutional angle. It also helps readers understand why the appearance belongs in a professional journal: it records participation in a public debate about implementation, not a clinical intervention.
For readers tracing Kotun’s work, the Munich entry offers a concise marker in that wider story. Its value lies in the question it preserves for decision-makers: what, precisely, should a digital health investment change, for whom, and how will that change be judged? Those questions remain relevant well beyond a three-day event. They turn a conference mention into a piece of context about accountability, evidence and the disciplined pursuit of useful innovation.